Cheryl A Opalack, DO Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 32 Sapling Drive, Kennett Square, PA 19348 Phone: 610-388-3190 Fax: 610-388-3191 |
News Archive
A so-called "club drug" - typically not used all that often by those who take it - can still have the potential to cause a lot of damage among some users, say University of Cincinnati researchers. Trials are underway to trace the effects of ecstasy and to see who's most at risk. The study is supported by $471,000 in federal stimulus funds awarded by the National Institutes of Health and spread out over two years.
Young female athletes who have stopped menstruating have a weakening in the quality of their bone structure that may predispose them to breaking a bone, despite getting plenty of weight-bearing exercise, a new study finds. The results will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston.
Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago Medical Center's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to antibodies.
Averaging 2,700 patients daily throughout the United States and hosting a critical 24/7 patient information call center, Hospice Partners On Call has selected 1Vault Networks, a secure colocation facility, to safeguard its powerful server infrastructure and guarantee call center continuity.
Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; raising the risk of heart failure.
› Verified 2 days ago